Greg Glenn

Gregory Glenn, MD, is CEO of Pinion Immunotherapeutics, developing mRNA-LNP immunotherapeutics for chronic viral diseases and cancers. With over 30 years in biotech, he led R&D at Novavax (NUVAXOVID COVID-19 and R21 malaria vaccines), founded IOMAI Corporation, and served as a U.S. Army physician, retiring as Lt. Col. He is an Elder at Fourth Presbyterian Church in Bethesda, MD.